| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -75 @ USD 139.9 | USD -10,493 | The ETF sold 75 shares of DVA on 2025-05-14. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,084 The average price that the ETF previously sold DVA share for is USD 153.818 which is higher than the selling price of USD 139.9 on 2025-05-14. |
| CRL - Creightons Plc | SELL | -84 @ USD 138.95 | USD -11,672 | The ETF sold 84 shares of CRL on 2025-05-14. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -17.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,460 The average price that the ETF previously sold CRL share for is USD 190.309 which is higher than the selling price of USD 138.95 on 2025-05-14. |
| TECH - Bio-Techne Corp | SELL | -261 @ USD 47.86 | USD -12,491 | The ETF sold 261 shares of TECH on 2025-05-14. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -26.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,475 The average price that the ETF previously sold TECH share for is USD 71.2642 which is higher than the selling price of USD 47.86 on 2025-05-14. |
| MRNA - Moderna Inc | SELL | -552 @ USD 24.02 | USD -13,259 | The ETF sold 552 shares of MRNA on 2025-05-14. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -32.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,277 The average price that the ETF previously sold MRNA share for is USD 42.1217 which is higher than the selling price of USD 24.02 on 2025-05-14. |
| HSIC - Henry Schein Inc | SELL | -207 @ USD 70.08 | USD -14,507 | The ETF sold 207 shares of HSIC on 2025-05-14. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 570 The average price that the ETF previously sold HSIC share for is USD 71.1067 which is higher than the selling price of USD 70.08 on 2025-05-14. |
| SOLV - Solventum Corp. | SELL | -222 @ USD 71.14 | USD -15,793 | The ETF sold 222 shares of SOLV on 2025-05-14. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 668 The average price that the ETF previously sold SOLV share for is USD 70.1911 so the ETF has sold 222 shares on 2025-05-14 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -267 @ USD 61.16 | USD -16,330 | The ETF sold 267 shares of INCY on 2025-05-14. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,095 The average price that the ETF previously sold INCY share for is USD 72.8372 which is higher than the selling price of USD 61.16 on 2025-05-14. |
| VTRS - Viatris Inc | SELL | -2,004 @ USD 8.42 | USD -16,874 | The ETF sold 2004 shares of VTRS on 2025-05-14. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -19.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,965 The average price that the ETF previously sold VTRS share for is USD 12.254 which is higher than the selling price of USD 8.42 on 2025-05-14. |
| UHS - Universal Health Services Inc | SELL | -93 @ USD 187.83 | USD -17,468 | The ETF sold 93 shares of UHS on 2025-05-14. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of USD 116 The average price that the ETF previously sold UHS share for is USD 192.705 which is higher than the selling price of USD 187.83 on 2025-05-14. |
| RVTY - Revvity Inc. | SELL | -204 @ USD 91.02 | USD -18,568 | The ETF sold 204 shares of RVTY on 2025-05-14. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,276 The average price that the ETF previously sold RVTY share for is USD 114.398 which is higher than the selling price of USD 91.02 on 2025-05-14. |
| HOLX - Hologic Inc | SELL | -372 @ USD 55.36 | USD -20,594 | The ETF sold 372 shares of HOLX on 2025-05-14. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,293 The average price that the ETF previously sold HOLX share for is USD 72.5913 which is higher than the selling price of USD 55.36 on 2025-05-14. |
| ALGN - Align Technology Inc | SELL | -117 @ USD 187.65 | USD -21,955 | The ETF sold 117 shares of ALGN on 2025-05-14. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 72 The average price that the ETF previously sold ALGN share for is USD 216.087 which is higher than the selling price of USD 187.65 on 2025-05-14. |
| WST - West Pharmaceutical Services Inc | SELL | -117 @ USD 206.69 | USD -24,183 | The ETF sold 117 shares of WST on 2025-05-14. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -19.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,804 The average price that the ETF previously sold WST share for is USD 306.918 which is higher than the selling price of USD 206.69 on 2025-05-14. |
| BAX - Baxter International Inc | SELL | -840 @ USD 30.32 | USD -25,469 | The ETF sold 840 shares of BAX on 2025-05-14. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,521 The average price that the ETF previously sold BAX share for is USD 32.477 which is higher than the selling price of USD 30.32 on 2025-05-14. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -336 @ USD 80.47 | USD -27,038 | The ETF sold 336 shares of COO on 2025-05-14. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,896 The average price that the ETF previously sold COO share for is USD 96.476 which is higher than the selling price of USD 80.47 on 2025-05-14. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -90 @ USD 311.62 | USD -28,046 | The ETF sold 90 shares of MOH on 2025-05-14. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 193 The average price that the ETF previously sold MOH share for is USD 306.367 so the ETF has sold 90 shares on 2025-05-14 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -90 @ USD 311.62 | USD -28,046 | The ETF sold 90 shares of MOH on 2025-05-14. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 193 The average price that the ETF previously sold MOH share for is USD 306.367 so the ETF has sold 90 shares on 2025-05-14 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -240 @ USD 120.37 | USD -28,889 | The ETF sold 240 shares of BIIB on 2025-05-14. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -17.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,066 The average price that the ETF previously sold BIIB share for is USD 158.672 which is higher than the selling price of USD 120.37 on 2025-05-14. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -327 @ USD 95.33 | USD -31,173 | The ETF sold 327 shares of ZBH on 2025-05-14. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -11.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,849 The average price that the ETF previously sold ZBH share for is USD 107.595 which is higher than the selling price of USD 95.33 on 2025-05-14. |
| DGX - Quest Diagnostics Incorporated | SELL | -186 @ USD 172.48 | USD -32,081 | The ETF sold 186 shares of DGX on 2025-05-14. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 1,016 The average price that the ETF previously sold DGX share for is USD 159.09 so the ETF has sold 186 shares on 2025-05-14 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -135 @ USD 242.37 | USD -32,720 | The ETF sold 135 shares of LH on 2025-05-14. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 0.5% higher than average price of previous purchases. This sale made a profit of USD 147 The average price that the ETF previously sold LH share for is USD 235.794 so the ETF has sold 135 shares on 2025-05-14 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -96 @ USD 345.38 | USD -33,156 | The ETF sold 96 shares of WAT on 2025-05-14. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,293 The average price that the ETF previously sold WAT share for is USD 372.987 which is higher than the selling price of USD 345.38 on 2025-05-14. |
| WAT - Waters Corporation | SELL | -96 @ USD 345.38 | USD -33,156 | The ETF sold 96 shares of WAT on 2025-05-14. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,293 The average price that the ETF previously sold WAT share for is USD 372.987 which is higher than the selling price of USD 345.38 on 2025-05-14. |
| PODD - Insulet Corporation | SELL | -114 @ USD 321.41 | USD -36,641 | The ETF sold 114 shares of PODD on 2025-05-14. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 19.8% higher than average price of previous purchases. This sale made a profit of USD 6,068 The average price that the ETF previously sold PODD share for is USD 261.135 so the ETF has sold 114 shares on 2025-05-14 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -162 @ USD 227.5 | USD -36,855 | The ETF sold 162 shares of STE on 2025-05-14. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 877 The average price that the ETF previously sold STE share for is USD 214.745 so the ETF has sold 162 shares on 2025-05-14 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -33 @ USD 1117.81 | USD -36,888 | The ETF sold 33 shares of MTD on 2025-05-14. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,012 The average price that the ETF previously sold MTD share for is USD 1241.82 which is higher than the selling price of USD 1117.81 on 2025-05-14. |
| MTD - Mettler-Toledo International Inc | SELL | -33 @ USD 1117.81 | USD -36,888 | The ETF sold 33 shares of MTD on 2025-05-14. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,012 The average price that the ETF previously sold MTD share for is USD 1241.82 which is higher than the selling price of USD 1117.81 on 2025-05-14. |
| IQV - IQVIA Holdings Inc | SELL | -276 @ USD 141.82 | USD -39,142 | The ETF sold 276 shares of IQV on 2025-05-14. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -26.0% lower than average price of previous purchases. This resulted in an overall loss of USD 13,744 The average price that the ETF previously sold IQV share for is USD 198.653 which is higher than the selling price of USD 141.82 on 2025-05-14. |
| HUM - Humana Inc | SELL | -198 @ USD 230.47 | USD -45,633 | The ETF sold 198 shares of HUM on 2025-05-14. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,834 The average price that the ETF previously sold HUM share for is USD 278.439 which is higher than the selling price of USD 230.47 on 2025-05-14. |
| HUM - Hummingbird Resources PLC | SELL | -198 @ USD 230.47 | USD -45,633 | The ETF sold 198 shares of HUM on 2025-05-14. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,834 The average price that the ETF previously sold HUM share for is USD 278.439 which is higher than the selling price of USD 230.47 on 2025-05-14. |
| CNC - Concurrent Technologies Plc | SELL | -828 @ USD 59.47 | USD -49,241 | The ETF sold 828 shares of CNC on 2025-05-14. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -1.1% lower than average price of previous purchases. This resulted in an overall loss of USD 537 The average price that the ETF previously sold CNC share for is USD 60.0719 which is higher than the selling price of USD 59.47 on 2025-05-14. |
| A - Agilent Technologies Inc | SELL | -468 @ USD 111.52 | USD -52,191 | The ETF sold 468 shares of A on 2025-05-14. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 8,139 The average price that the ETF previously sold A share for is USD 133.045 which is higher than the selling price of USD 111.52 on 2025-05-14. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -750 @ USD 72.84 | USD -54,630 | The ETF sold 750 shares of GEHC on 2025-05-14. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,996 The average price that the ETF previously sold GEHC share for is USD 81.4578 which is higher than the selling price of USD 72.84 on 2025-05-14. |
| DXCM - DexCom Inc | SELL | -648 @ USD 86.52 | USD -56,065 | The ETF sold 648 shares of DXCM on 2025-05-14. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 5,596 The average price that the ETF previously sold DXCM share for is USD 75.3391 so the ETF has sold 648 shares on 2025-05-14 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -399 @ USD 148.41 | USD -59,216 | The ETF sold 399 shares of CAH on 2025-05-14. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 15.6% higher than average price of previous purchases. This sale made a profit of USD 8,012 The average price that the ETF previously sold CAH share for is USD 121.669 so the ETF has sold 399 shares on 2025-05-14 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -240 @ USD 246.99 | USD -59,278 | The ETF sold 240 shares of RMD on 2025-05-14. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of USD 3,065 The average price that the ETF previously sold RMD share for is USD 239.796 so the ETF has sold 240 shares on 2025-05-14 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -132 @ USD 509.42 | USD -67,243 | The ETF sold 132 shares of IDXX on 2025-05-14. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 15.6% higher than average price of previous purchases. This sale made a profit of USD 9,058 The average price that the ETF previously sold IDXX share for is USD 425.231 so the ETF has sold 132 shares on 2025-05-14 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -972 @ USD 76.75 | USD -74,601 | The ETF sold 972 shares of EW on 2025-05-14. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of USD 5,317 The average price that the ETF previously sold EW share for is USD 70.1829 so the ETF has sold 972 shares on 2025-05-14 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -282 @ USD 279.15 | USD -78,720 | The ETF sold 282 shares of COR on 2025-05-14. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of USD 6,910 The average price that the ETF previously sold COR share for is USD 245.105 so the ETF has sold 282 shares on 2025-05-14 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -471 @ USD 171.02 | USD -80,550 | The ETF sold 471 shares of BDX on 2025-05-14. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -24.5% lower than average price of previous purchases. This resulted in an overall loss of USD 26,173 The average price that the ETF previously sold BDX share for is USD 225.18 which is higher than the selling price of USD 171.02 on 2025-05-14. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -171 @ USD 571.36 | USD -97,703 | The ETF sold 171 shares of REGN on 2025-05-14. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -18.9% lower than average price of previous purchases. This resulted in an overall loss of USD 22,768 The average price that the ETF previously sold REGN share for is USD 753.725 which is higher than the selling price of USD 571.36 on 2025-05-14. |
| HCA - HCA Holdings Inc | SELL | -291 @ USD 367.5 | USD -106,943 | The ETF sold 291 shares of HCA on 2025-05-14. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 8,588 The average price that the ETF previously sold HCA share for is USD 325.927 so the ETF has sold 291 shares on 2025-05-14 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -732 @ USD 154.92 | USD -113,401 | The ETF sold 732 shares of ZTS on 2025-05-14. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,003 The average price that the ETF previously sold ZTS share for is USD 172 which is higher than the selling price of USD 154.92 on 2025-05-14. |
| CVS - CVS Health Corp | SELL | -2,064 @ USD 60.04 | USD -123,923 | The ETF sold 2064 shares of CVS on 2025-05-14. The shares were previously bought for an average price of USD 62.9223. The CVS Health Corp shares were sold for -4.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,949 The average price that the ETF previously sold CVS share for is USD 55.2109 so the ETF has sold 2064 shares on 2025-05-14 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -447 @ USD 303.35 | USD -135,597 | The ETF sold 447 shares of CI on 2025-05-14. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,997 The average price that the ETF previously sold CI share for is USD 312.953 which is higher than the selling price of USD 303.35 on 2025-05-14. |
| MCK - McKesson Corporation | SELL | -204 @ USD 682.28 | USD -139,185 | The ETF sold 204 shares of MCK on 2025-05-14. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 9.8% higher than average price of previous purchases. This sale made a profit of USD 12,383 The average price that the ETF previously sold MCK share for is USD 599.864 so the ETF has sold 204 shares on 2025-05-14 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -378 @ USD 374.29 | USD -141,482 | The ETF sold 378 shares of ELV on 2025-05-14. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 13,782 The average price that the ETF previously sold ELV share for is USD 402.49 which is higher than the selling price of USD 374.29 on 2025-05-14. |
| ELV - Elevance Health Inc | SELL | -378 @ USD 374.29 | USD -141,482 | The ETF sold 378 shares of ELV on 2025-05-14. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of USD 13,782 The average price that the ETF previously sold ELV share for is USD 402.49 which is higher than the selling price of USD 374.29 on 2025-05-14. |
| BMY - Bloomsbury Publishing Plc | SELL | -3,318 @ USD 44.12 | USD -146,390 | The ETF sold 3318 shares of BMY on 2025-05-14. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -23.0% lower than average price of previous purchases. This resulted in an overall loss of USD 43,780 The average price that the ETF previously sold BMY share for is USD 56.826 which is higher than the selling price of USD 44.12 on 2025-05-14. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -417 @ USD 421.16 | USD -175,624 | The ETF sold 417 shares of VRTX on 2025-05-14. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 23,974 The average price that the ETF previously sold VRTX share for is USD 464.78 which is higher than the selling price of USD 421.16 on 2025-05-14. |
| MDT - Medtronic PLC | SELL | -2,094 @ USD 84.25 | USD -176,420 | The ETF sold 2094 shares of MDT on 2025-05-14. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 9,416 The average price that the ETF previously sold MDT share for is USD 85.3897 which is higher than the selling price of USD 84.25 on 2025-05-14. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 187.82 | USD -196,084 | The ETF sold 1044 shares of DHR on 2025-05-14. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 30,132 The average price that the ETF previously sold DHR share for is USD 232.576 which is higher than the selling price of USD 187.82 on 2025-05-14. |
| DHR - Danaher Corporation | SELL | -1,044 @ USD 187.82 | USD -196,084 | The ETF sold 1044 shares of DHR on 2025-05-14. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 30,132 The average price that the ETF previously sold DHR share for is USD 232.576 which is higher than the selling price of USD 187.82 on 2025-05-14. |
| GILD - Guild Esports Plc | SELL | -2,034 @ USD 98.38 | USD -200,105 | The ETF sold 2034 shares of GILD on 2025-05-14. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,379 The average price that the ETF previously sold GILD share for is USD 94.2571 so the ETF has sold 2034 shares on 2025-05-14 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -9,255 @ USD 22.02 | USD -203,795 | The ETF sold 9255 shares of PFE on 2025-05-14. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -14.7% lower than average price of previous purchases. This resulted in an overall loss of USD 35,045 The average price that the ETF previously sold PFE share for is USD 26.0379 which is higher than the selling price of USD 22.02 on 2025-05-14. |
| SYK - Stryker Corporation | SELL | -558 @ USD 386.32 | USD -215,567 | The ETF sold 558 shares of SYK on 2025-05-14. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 3,678 The average price that the ETF previously sold SYK share for is USD 374.459 so the ETF has sold 558 shares on 2025-05-14 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -876 @ USD 262.28 | USD -229,757 | The ETF sold 876 shares of AMGN on 2025-05-14. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 35,863 The average price that the ETF previously sold AMGN share for is USD 289.85 which is higher than the selling price of USD 262.28 on 2025-05-14. |
| BSX - MULSTRXSSXIMETFP | SELL | -2,406 @ USD 102.95 | USD -247,698 | The ETF sold 2406 shares of BSX on 2025-05-14. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 10,261 The average price that the ETF previously sold BSX share for is USD 90.1056 so the ETF has sold 2406 shares on 2025-05-14 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -2,406 @ USD 102.95 | USD -247,698 | The ETF sold 2406 shares of BSX on 2025-05-14. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 10,261 The average price that the ETF previously sold BSX share for is USD 90.1056 so the ETF has sold 2406 shares on 2025-05-14 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -624 @ USD 406.05 | USD -253,375 | The ETF sold 624 shares of TMO on 2025-05-14. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -22.2% lower than average price of previous purchases. This resulted in an overall loss of USD 72,197 The average price that the ETF previously sold TMO share for is USD 525.328 which is higher than the selling price of USD 406.05 on 2025-05-14. |
| MRK - Merck & Company Inc | SELL | -4,125 @ USD 73.47 | USD -303,064 | The ETF sold 4125 shares of MRK on 2025-05-14. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -20.0% lower than average price of previous purchases. This resulted in an overall loss of USD 75,905 The average price that the ETF previously sold MRK share for is USD 99.2923 which is higher than the selling price of USD 73.47 on 2025-05-14. |
| MRK - Marks Electrical Group PLC | SELL | -4,125 @ USD 73.47 | USD -303,064 | The ETF sold 4125 shares of MRK on 2025-05-14. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -20.0% lower than average price of previous purchases. This resulted in an overall loss of USD 75,905 The average price that the ETF previously sold MRK share for is USD 99.2923 which is higher than the selling price of USD 73.47 on 2025-05-14. |
| ISRG - Intuitive Surgical Inc | SELL | -579 @ USD 565.94 | USD -327,679 | The ETF sold 579 shares of ISRG on 2025-05-14. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of USD 14,382 The average price that the ETF previously sold ISRG share for is USD 529.755 so the ETF has sold 579 shares on 2025-05-14 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -2,826 @ USD 128.56 | USD -363,311 | The ETF sold 2826 shares of ABT on 2025-05-14. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of USD 4,312 The average price that the ETF previously sold ABT share for is USD 117.404 so the ETF has sold 2826 shares on 2025-05-14 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,497 @ USD 308.01 | USD -461,091 | The ETF sold 1497 shares of UNH on 2025-05-14. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -41.2% lower than average price of previous purchases. This resulted in an overall loss of USD 323,541 The average price that the ETF previously sold UNH share for is USD 563.901 which is higher than the selling price of USD 308.01 on 2025-05-14. |
| ABBV - AbbVie Inc | SELL | -2,874 @ USD 177.44 | USD -509,963 | The ETF sold 2874 shares of ABBV on 2025-05-14. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -8.3% lower than average price of previous purchases. This resulted in an overall loss of USD 46,317 The average price that the ETF previously sold ABBV share for is USD 185.251 which is higher than the selling price of USD 177.44 on 2025-05-14. |
| JNJ - Johnson & Johnson | SELL | -3,921 @ USD 146.36 | USD -573,878 | The ETF sold 3921 shares of JNJ on 2025-05-14. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 45,558 The average price that the ETF previously sold JNJ share for is USD 152.726 which is higher than the selling price of USD 146.36 on 2025-05-14. |
| LLY - Eli Lilly and Company | SELL | -1,281 @ USD 715.56 | USD -916,632 | The ETF sold 1281 shares of LLY on 2025-05-14. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 156,392 The average price that the ETF previously sold LLY share for is USD 796.56 which is higher than the selling price of USD 715.56 on 2025-05-14. |